Alongside Cenovus' Environmental Opportunity Fund in the $19.5m series B round for General Fusion were Bezos Expeditions, the family office of Jeff Bezos, founder and head of online retailer Amazon, and venture capital firms.

Mitsui's corporate venturing unit has joined the consortium investing $45m in clean-tech firm BioAmber and floated Boingo Wireless.

BlueRun also participated in 140's first $2m round, which also included angel investors.

As part of the $12m B round investment, Heath Lukatch and Tiba Aynechi, a partner and principal in Novo Ventures respectively, join Cianna's board.

In return for selling some equity, SCI has struck a global strategic alliance with semiconductor company Intel and raised more than $19m from General Electric (GE) and venture capital firm Triangle Peak Partners.

VC firms Contour Venture Partners and New Venture Partners are in TimeSight's consortium, while a regulatory filing said the portfolio company raised $3.2m from 10 investors.

Novartis Venture Fund and Venture Investors, a venture capital (VC) firm investing in university technology transfer start-ups throughout the Midwest of America, co-led the $22m B round for Akebia Therapeutics.

The UK-based National Endowment for Science, Technology and the Arts (Nesta), which is publicly-funded but about to become a charity and quasi-corporate venturer, invested in the B round along with venture capital firms Nauta Capital and Eden Ventures.

Energy Technology Ventures, a General Electric-NRG Energy-ConocoPhillips joint venture, and Aster Capital, backed by European industrial groups Alstom, Schneider Electric and Rhodia, are two funds backing Ioxus, a US-based battery maker.

Alongside SR One backing F-star are Germany-based drugs maker Merck Serono's corporate venturing unit, MP Healthcare Venture, a jointly owned subsidiary of Mitsubishi Tanabe Pharma and its parent company Mitsubishi Chemical, and venture capital firms Atlas Venture, Aescap Venture, Novo Ventures and TVM Capital.